Ahmed Abbas
Assiut, Cairo Governorate, 002, Egypt
NCT Number: NCT02714699
The study aims to determine the efficacy of oral hyoscine butyl bromide versus diclofenac potassium on the pain scores during office hysteroscopy
Looking for future studies?
Notify Me20 year and older
Female
Interventional
Phase 2 / Phase 3
Assiut, Cairo Governorate, 002, Egypt
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
patients will take oral diclofenac potassium; two tablets (cataflam 25 mg) and one tablet placebo one hour before the procedure
Other names: cataflam
patients will take oral hyoscine-N- butyl bromide; 2 tablets (buscopan 10 mg) one hour before the procedure
Other names: buscopan
patients will take oral placebo; 2 tablets one hour before the procedure
Time frame: intraoperative
Assiut University
Other
Randomized Clinical Trial of Oral Hyoscine Butyl Bromide Versus Diclofenac Potassium in Reducing Pain During Office Hysteroscopy
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04660214
Digestive System Diseases, Diverticular Diseases
Valladolid, Spain
View Trial DetailsNCT06645457
Anxiety, Anxiety Disorders
Muğla, Turkey (Türkiye)
View Trial DetailsNCT07360041
Calculi, Calculus
Cairo, Cairo Governorate, Egypt
View Trial DetailsNCT07143435
Anemia, Anemia, Hypochromic
Kassala, Sudan
View Trial Details